Company intelligence / Profile preview
Beijing Handian Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Beijing Handian Pharmaceutical is a private Chinese pharmaceutical company specializing in the development and production of traditional Chinese medicines, with a focus on herbal formulations for nervous system diseases. Its lead product, Ziyedan Capsule, is approved in China for the treatment of flank pain. The company has been active since 2005 and operates as a national high-tech enterprise integrating production, education, and research.[1][3][4] No clinical trial results or broader pipeline data are publicly available.
- Therapeutic areas
- NeurologyNephrology
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Beijing Handian Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Handian Pharmaceutical.